H-CYTE
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of H-CYTE generated cash of -$1,913,738, which is more than the previous year. Cash used in financing activities reached the amount of $1,818,097 last year. Net change in cash is therefore $52,157.
Cash Flow
| 2013 | -573.73K | -3.93K | 3.18M |
|---|---|---|---|
| 2014 | -2.75M | -23.66K | 6.86M |
| 2015 | -5.98M | -1.15M | 2.02M |
| 2016 | -5.42M | 414.86K | 4.33M |
| 2017 | -5.59M | -16.68K | 4.95M |
| 2018 | -2.34M | 150K | 1.99M |
| 2019 | -12.29M | -393.02K | 14.03M |
| 2020 | -7.25M | -2.28K | 7.47M |
| 2021 | -4.80M | -7.83K | 3.27M |
| 2022 | -1.91M | 469 | 1.81M |
HCYT Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 95.17K | 1.64M | 1.42M | 69.62K | 245.02K | 892.81K | 1.57M | 6.68M | 2.60M | -577.67K |
Operating activities | ||||||||||
Net income | -10.29M | -4.79M | -6.45M | -29.80M | -4.90M | -6.45M | -16.22M | -6.52M | -2.93M | -673.33K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 14.21K | 15.82K | 81.47K | 834.29K | 23.91K | 27.1K | 200.91K | 433.09K | 2.68K | 472 |
Stock-based compensation expense | 585.71K | 1.18M | 643 | 1.78M | 0 | 0 | 0 | 0 | 0 | 36.25K |
| Deferred income tax benefit | 585.71K | 1.18M | 643 | 1.78M | 0 | 0 | 0 | 0 | 0 | 36.25K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -54.09K | -27.9K | 16.66K | 48.19K | 11.31K | -157.06K | 33.04K | -33.04K | 0 | 0 |
Inventories | 0 | -89.8K | 687.38K | -988.39K | 163.25K | -294.71K | 0 | 15.05K | 0 | 0 |
Accounts payable | 364.60K | -421.67K | -478.57K | 121.90K | 633.77K | -17.23K | -52.58K | -164.14K | 104.55K | 36.12K |
Cash generated by operating activities | -1.91M | -4.80M | -7.25M | -12.29M | -2.34M | -5.59M | -5.42M | -5.98M | -2.75M | -573.73K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -7.83K | -2.28K | -20.68K | 0 | -16.68K | -85.13K | -7.05K | -23.66K | -3.93K |
Acquisitions Net | 0 | 0 | 0 | -372.33K | 150K | 0 | 500K | -1.15M | 0 | 0 |
Cash generated by investing activities | 469 | -7.83K | -2.28K | -393.02K | 150K | -16.68K | 414.86K | -1.15M | -23.66K | -3.93K |
Financing activities | ||||||||||
Common Stock Issued | 254.99K | 0 | 0 | 4.33M | 774.50K | 3.83M | 2.77M | 1.08M | 6.73M | 3.21M |
Payments for dividends | 0 | 0 | 0 | -14.68K | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 147.32K | 383.69M | 0 | -50K | 57.81K | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -52.83K | -10.93K | 0 | -171.07K | 0 | -136.02K | 0 | 0 | 0 |
Cash used in financing activities | 1.81M | 3.27M | 7.47M | 14.03M | 1.99M | 4.95M | 4.33M | 2.02M | 6.86M | 3.18M |
Net Change In Cash | 52.15K | -1.54M | 216.54K | 1.35M | -197.73K | -647.78K | -677.35K | -5.11M | 4.07M | 3.18M |
Cash at end of period | 147.32K | 95.17K | 1.64M | 1.42M | 47.29K | 245.02K | 892.81K | 1.57M | 6.68M | 2.60M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |